Formedics - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 3,325,639 | 4,213,956 | 4,615,890 | 5,145,327 | 5,782,295 | 6,315,035 | 7,346,408 | 8,406,522 |
| Profit before tax | 568,831 | 363,053 | 664,298 | 784,128 | 837,016 | 1,038,496 | 1,164,296 | 1,409,503 |
| Net profit | 481,399 | 261,975 | 554,560 | 674,809 | 706,263 | 878,047 | 992,359 | 1,171,127 |
| Equity | 2,091,390 | 2,120,797 | 2,580,829 | 2,635,638 | 840,279 | 1,473,157 | 1,660,821 | 2,031,947 |
| Liabilities | 871,522 | 1,067,299 | 804,147 | 1,185,951 | 1,153,553 | 1,004,945 | 1,180,516 | 1,789,520 |
| Non-current assets | 782,790 | 1,241,400 | 1,888,673 | 2,208,316 | 255,852 | 369,385 | 372,470 | 479,735 |
| Current assets | 2,245,192 | 1,964,224 | 1,508,808 | 1,627,704 | 1,732,382 | 2,102,410 | 2,460,968 | 3,333,081 |
| Total assets | 3,027,982 | 3,205,624 | 3,397,481 | 3,836,020 | 1,988,234 | 2,471,795 | 2,833,438 | 3,812,816 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 490,046 | 571,784 | 660,258 |
| Social insurance contributions | - | - | - | - | - | 174,621 | 174,694 | 183,088 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +15.7% | +26.7% | +9.5% | +11.5% | +12.4% | +9.2% | +16.3% | +14.4% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 15.9% | 8.2% | 16.3% | 17.6% | 35.5% | 35.5% | 35.0% | 30.7% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 23.0% | 12.4% | 21.5% | 25.6% | 84.1% | 59.6% | 59.8% | 57.6% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 14.5% | 6.2% | 12.0% | 13.1% | 12.2% | 13.9% | 13.5% | 13.9% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 17.1% | 8.6% | 14.4% | 15.2% | 14.5% | 16.4% | 15.8% | 16.8% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.4 | 0.5 | 0.3 | 0.4 | 1.4 | 0.7 | 0.7 | 0.9 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 247,873 | 257,998 | 265,027 | 273,204 | 324,241 | 360,859 | 436,421 | 542,356 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Formedics - Social security debts
The company had no debts to Sodra
Formedics - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Formedics, UAB (code 124980311) is a Private Limited Liability Company operating in the wholesale of pharmaceutical and medical goods. In 2025, the latest financial year, the company generated revenue of €8.41M and net profit of €1.17M, maintaining a profit margin of 13.9%. Revenue increased by 14.4% year on year and by 33.1% over two years, showing steady top-line expansion from €6.32M in 2023 to €7.35M in 2024 and €8.41M in 2025. Net profit also improved from €878.0K in 2023 to €992.4K in 2024 and €1.17M in 2025. The balance sheet strengthened over the period, with total assets rising to €3.81M, equity to €2.03M, and liabilities to €1.79M in 2025. Equity accounted for 53.3% of assets, while debt to equity stood at 0.88. Efficiency indicators were solid, with asset turnover at 2.20x, ROE at 57.6%, and ROA at 30.7%. Revenue per employee reached €560.4K, with profit per employee at €78.1K.